Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:4.1.1.17 (
ornithine decarboxylase
)
6,351
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The levels at which the
ornithine decarboxylase
gene is regulated in murine erythroleukemic cells treated with N,N'-hexamethylene bisacetamide (N,N' diacetyl-
1,6-hexanediamine
) and with N-acetyl-
1,6-hexanediamine
, the monoacetylated catabolite of this inducer of erythrodifferentiation, have been investigated. Although these two molecules are structurally related and both cause a decrease in
ornithine decarboxylase
activity, they did not similarly affect
ornithine decarboxylase
mRNA. In the presence of 4 mM N,N'-hexamethylenebisacetamide, at the concentration generally used to induce differentiation in these cells, a decreased steady-state level of
ornithine decarboxylase
mRNA, due to decreased gene transcription, was observed. In the presence of N-acetyl-
1,6-hexanediamine
the decrease in enzyme activity was shown to be associated with a decrease in the half-life of the enzyme in the absence of a change in gene transcription. These results show that in proliferating cultured cells changes in ornithine-decarboxylase-gene transcription can be uncoupled from changes in cell growth and that N-acetyl-
1,6-hexanediamine
only regulates
ornithine decarboxylase
expression post-transcriptionally.
...
PMID:Regulation of ornithine decarboxylase in murine erythroleukemic cells by N,N'-diacetyl-1,6-hexanediamine and N-acetyl-1,6-hexanediamine. 291 34
The antiproliferative properties of inhibitors of polyamine synthesis were evaluated in cultured neuroblastoma and glioma cells. The diamines (1,3-propanediamine, 1,5-pentanediamine, and
1,6-hexanediamine
) dramatically decreased neuroblastoma replication and inhibited the rate-limiting enzyme,
ornithine decarboxylase
. Glioma cells were less sensitive to the diamines in spite of significant drug-induced decreases in enzyme activity. The fact that
ornithine decarboxylase
was inhibited in both cell lines with different effects on proliferation suggests that the activity of other enzymes in polyamine biosynthesis may be altered selectively by these inhibitors.
...
PMID:Antiproliferative effects of inhibitors of polyamine synthesis in tumors of neural origin. 720 97